These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8098364)

  • 1. Stereochemical aspects of the molecular pharmaceutics of ibuprofen.
    Romero AJ; Rhodes CT
    J Pharm Pharmacol; 1993 Apr; 45(4):258-62. PubMed ID: 8098364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamics of sublimation, crystal lattice energies, and crystal structures of racemates and enantiomers: (+)- and (+/-)-ibuprofen.
    Perlovich GL; Kurkov SV; Hansen LK; Bauer-Brandl A
    J Pharm Sci; 2004 Mar; 93(3):654-66. PubMed ID: 14762904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of physicochemical properties on the in vitro skin permeation of the enantiomers, racemate, and eutectics of ibuprofen for enhanced transdermal drug delivery.
    Yuan X; Capomacchia AC
    J Pharm Sci; 2013 Jun; 102(6):1957-1969. PubMed ID: 23589422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical aspects of dexibuprofen and racemic ibuprofen.
    Leising G; Resel R; Stelzer F; Tasch S; Lanziner A; Hantich G
    J Clin Pharmacol; 1996 Dec; 36(12 Suppl):3S-6S. PubMed ID: 9013377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity in structures of racemic and enantiomeric ibuprofen sodium dihydrates.
    Zhang Y; Grant DJ
    Acta Crystallogr C; 2005 Sep; 61(Pt 9):m435-8. PubMed ID: 16143769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall stability for the ibuprofen racemate: experimental and topological results leading to the pressure-temperature phase relationships between its racemate and conglomerate.
    Rietveld IB; Barrio M; Do B; Tamarit JL; Céolin R
    J Phys Chem B; 2012 May; 116(18):5568-74. PubMed ID: 22509723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chirality-dependent friction of bulk molecular solids.
    Yang D; Cohen AE
    Langmuir; 2014 Aug; 30(33):9972-6. PubMed ID: 25102409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial salt screening procedures for manufacturing ibuprofen.
    Lee T; Wang YW
    Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalemic mixtures preparation for optimized composition of ibuprofen solid dosage forms.
    Corvis Y; Guiblin N; Négrier P; Marenco I; Dembélé O; Espeau P
    Eur J Pharm Biopharm; 2021 Dec; 169():91-96. PubMed ID: 34571192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of configuration around the chiral carbon atoms on the crystal properties of ephedrinium and pseudoephedrinium salicylates.
    Duddu SP; Grant DJ
    Pharm Res; 1994 Nov; 11(11):1549-56. PubMed ID: 7870670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonamides as a subject to study molecular interactions in crystals and solutions: sublimation, solubility, solvation, distribution and crystal structure.
    Perlovich GL; Strakhova NN; Kazachenko VP; Volkova TV; Tkachev VV; Schaper KJ; Raevsky OA
    Int J Pharm; 2008 Feb; 349(1-2):300-13. PubMed ID: 17913412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical identification of (R)- and (S)-ibuprofen using residual dipolar couplings, NMR, and modeling.
    Marathias VM; Tawa GJ; Goljer I; Bach AC
    Chirality; 2007 Sep; 19(9):741-50. PubMed ID: 17094072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
    Soares FL; Carneiro RL
    J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical stability of solid dispersions of enantiomeric or racemic ibuprofen in stearic acid.
    Corvis Y; Négrier P; Espeau P
    J Pharm Sci; 2011 Dec; 100(12):5235-43. PubMed ID: 21905027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions.
    Ali W; Williams AC; Rawlinson CF
    Int J Pharm; 2010 May; 391(1-2):162-8. PubMed ID: 20214957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal and molecular structure of V-amylose complexed with ibuprofen.
    Le CAK; Ogawa Y; Dubreuil F; Grimaud F; Mazeau K; Ziegler GR; Tanwar S; Nishiyama Y; Potocki-Veronese G; Choisnard L; Wouessidjewe D; Putaux JL
    Carbohydr Polym; 2021 Jun; 261():117885. PubMed ID: 33766372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of structural characteristics of initial substances of ibuprofen and micronization impact].
    Lobanov NN; Khuchua NS; Obidchenko IuA; Abramovich RA
    Antibiot Khimioter; 2012; 57(3-4):3-8. PubMed ID: 22993933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of preferential enrichment, an unusual enantiomeric resolution phenomenon caused by polymorphic transition during crystallization of mixed crystals composed of two enantiomers.
    Tamura R; Fujimoto D; Lepp Z; Misaki K; Miura H; Takahashi H; Ushio T; Nakai T; Hirotsu K
    J Am Chem Soc; 2002 Nov; 124(44):13139-53. PubMed ID: 12405843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time monitoring of the mechanism of ibuprofen-cationic dextran crystanule formation using crystallization process informatics system (CryPRINS).
    Abioye AO; Chi GT; Simone E; Nagy Z
    Int J Pharm; 2016 Jul; 509(1-2):264-278. PubMed ID: 27260131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
    Huang J; Chen S; Guzei IA; Yu L
    J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.